TransCanada (TRP) said it has agreed to buy Columbia Pipeline (CPGX) for $25.50 a share, or roughly $13 billion. TransCanada's shares are down nearly two percent in Friday's session following the announcement. It's not Keystone, Cramer said. This involves a different, very important asset of TransCanada's, Cramer said -- a pipeline that runs from Alberta, Canada to the eastern United States. With the natural gas boom in Ohio and Pennsylvania, buyers no longer need to have natural gas shipped in from Western Canada. This acquisition boosts TransCanada's presence in the U.S., increasing its total coverage to around 57,000 miles of pipeline in North America. The deal is expected to close during the second half of the year.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.